We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,291

Scaffolding safety patent doesn’t stack up
  • The Commercial Bar Association of Victoria
  • Australia
  • November 26 2015

The owner of an innovation patent (Pro 3) for an invention relating to a system and components for safely enclosing handrails, stairways, walkways

Productivity Commission’s broad IP review in Australia - submissions due 30 November
  • K&L Gates
  • Australia
  • November 20 2015

There are two weeks left to make submissions to the Productivity Commission (the Commission) on the Commission's Intellectual Property Issues Paper

Gene patents rejected by the High Court
  • Davies Collison Cave
  • Australia
  • November 18 2015

In a decision handed down on 7 October 2015, the High Court has unanimously allowed the appeal from the decision of the Full Federal Court in D'Arcy

Patent eligibility in Australia: the winding road ahead
  • Watermark Patent & Trade Marks Attorneys
  • Australia
  • November 6 2015

As well as much other debate, the High Court’s decision in D’Arcy V Myriad Genetics has created uncertainty in terms of the patent eligibility of

Patentability of genetic material
  • ENSafrica
  • Australia
  • November 6 2015

The patentability of genetic material has again come into the spotlight with the recent high court decision in Australia in the Myriad Genetics Inc

Australian Patent Office seeks comment on proposed examination practice arising from the Myriad Genetics High Court decision
  • K&L Gates
  • Australia
  • November 6 2015

The Australian Patent Office has commenced a public consultation on their proposed changes to examination practice, as a result of the recent High

Courts review gene patents
  • Husch Blackwell LLP
  • Australia, Global
  • November 2 2015

The patentability of genes is under scrutiny all over the world. Several weeks ago, the High Court of Australia shed light upon the patentability of

When inventive steps become routine...greater hurdles for applicants with claims directed to antibodies
  • Freehills Patent Attorneys
  • Australia
  • October 29 2015

The development of monoclonal antibodies has revolutionised medical science, and the use of these molecules in the development of future therapies

IP in depth: status update on Australian business method and software patent applications
  • Fisher Adams Kelly
  • Australia
  • October 28 2015

In a year that has seen important judicial decisions in Australia on a range of controversial IP topics the law of the land regarding patents for

The pulse webinar: patent law in the life sciences sector - US and Australian perspectives
  • DLA Piper LLP
  • Australia, USA
  • October 28 2015

On 28 October 2015 DLA Piper Life Sciences Global Co-Chair, Dr. Lisa Haile and DLA Piper Life Sciences & Intellectual Property Partner, Nicholas